Daiwa Securities Group Inc. Bridge Bio Pharma, Inc. Transaction History

Daiwa Securities Group Inc.

$22.4 Billion
Q4 2024

A detailed history of Daiwa Securities Group Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 624 shares of BBIO stock, worth $22,994. This represents 0.0% of its overall portfolio holdings.

Number of Shares

624

Previous 31,709 98.03%

Holding current value

$22,994

Previous $807,000 97.89%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$22.35 - $29.5 $694,749 - $917,007	-31,085 Reduced 98.03%	624 $17,000
Q3 2024 Nov 12, 2024	SELL	$23.91 - $31.3 $95,640 - $125,200	-4,000 Reduced 11.2%	31,709 $807,000
Q2 2024 Aug 07, 2024	BUY	$23.0 - $31.04 $806,357 - $1.09 Million	35,059 Added 5393.69%	35,709 $904,000
Q1 2024 May 02, 2024	SELL	$27.35 - $40.45 $1,668 - $2,467	-61 Reduced 8.58%	650 $20,000
Q4 2023 Jan 31, 2024	BUY	$24.02 - $43.89 $3,867 - $7,066	161 Added 29.27%	711 $29,000
Q2 2023 Jul 31, 2023	SELL	$13.29 - $18.01 $102,957 - $139,523	-7,747 Reduced 93.37%	550 $9,000
Q1 2023 May 02, 2023	BUY	$7.17 - $18.55 $10,912 - $28,233	1,522 Added 22.46%	8,297 $138,000
Q4 2022 Feb 06, 2023	SELL	$6.74 - $11.52 $13,702 - $23,420	-2,033 Reduced 23.08%	6,775 $52,000
Q3 2022 Nov 02, 2022	BUY	$7.94 - $12.36 $65,568 - $102,068	8,258 Added 1501.45%	8,808 $88,000
Q2 2022 Aug 09, 2022	BUY	$5.21 - $12.14 $630 - $1,468	121 Added 28.21%	550 $5,000
Q4 2021 Feb 03, 2022	SELL	$11.38 - $53.41 $955 - $4,486	-84 Reduced 16.37%	429 $7,000
Q3 2021 Nov 05, 2021	BUY	$46.87 - $64.24 $10,217 - $14,004	218 Added 73.9%	513 $24,000
Q1 2021 May 03, 2021	BUY	$55.47 - $72.35 $3,550 - $4,630	64 Added 27.71%	295 $18,000
Q4 2020 Feb 04, 2021	SELL	$38.38 - $71.11 $17,885 - $33,137	-466 Reduced 66.86%	231 $16,000
Q4 2019 Jan 31, 2020	BUY	$17.96 - $46.63 $12,518 - $32,501	697 New	697 $24,000

Others Institutions Holding BBIO

# of Institutions

321

Shares Held

176M

Call Options Held

13M

Put Options Held

2.48M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.46B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Bridge Bio Pharma, Inc. Transaction History